Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Prostate cancer classification using 3D deep learning and ultrasound video clips: a multicenter study
1
Zitationen
20
Autoren
2025
Jahr
Abstract
Objective: This study aimed to evaluate the effectiveness of deep-learning models using transrectal ultrasound (TRUS) video clips in predicting prostate cancer. Methods: We manually segmented TRUS video clips from consecutive men who underwent examination with EsaoteMyLab™ Class C ultrasonic diagnostic machines between January 2021 and October 2022. The deep learning-inflated 3D ConvNet (I3D) model was internally validated using split-sample validation on the development set through cross-validation. The final performance was evaluated on two external test sets using geographic validation. We compared the results obtained from a ResNet 50 model, four ML models, and the diagnosis provided by five senior sonologists. Results: A total of 815 men (median age: 71 years; IQR: 67-77 years) were included. The development set comprised 552 men (median age: 71 years; IQR: 67-77 years), the internal test set included 93 men (median age: 71 years; IQR: 67-77 years), external test set 1 consisted of 96 men (median age: 70 years; IQR: 65-77 years), and external test set 2 had 74 men (median age: 72 years; IQR: 68-78 years). The I3D model achieved diagnostic classification AUCs greater than 0.86 in the internal test set as well as in the independent external test sets 1 and 2. Moreover, it demonstrated greater consistency in sensitivity, specificity, and accuracy compared to pathological diagnosis (kappa > 0.62, p < 0.05). It exhibited a statistically significant superior ability to classify and predict prostate cancer when compared to other AI models, and the diagnoses provided by sonologists (p<0.05). Conclusion: The I3D model, utilizing TRUS prostate video clips, proved to be valuable for classifying and predicting prostate cancer.
Ähnliche Arbeiten
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 · 5.712 Zit.
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 · 5.470 Zit.
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 · 5.244 Zit.
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 · 4.558 Zit.
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 · 4.503 Zit.
Autoren
Institutionen
- Wenzhou Medical University(CN)
- Dongyang People's Hospital(CN)
- Zhejiang A & F University(CN)
- Zhejiang University of Science and Technology(CN)
- Zhejiang University(CN)
- Quzhou University(CN)
- Quzhou City People's Hospital(CN)
- Zhejiang Cancer Hospital(CN)
- Hangzhou Academy of Agricultural Sciences(CN)
- Hangzhou Cancer Hospital(CN)
- Beijing Tian Tan Hospital(CN)
- Taizhou Central Hospital(CN)
- Zhejiang Taizhou Hospital(CN)
- Taizhou People's Hospital(CN)
- Nantong University(CN)
- Taizhou Vocational and Technical College(CN)
- Zhejiang Lab(CN)